Author Archives: zp154479

In the article, “F.D.A Panel Backs Pre-surgery Drug for Breast Cancer”, Andrew Pollack talks about the first approval of a cancer drug by a federal advisory committee to the Food and Drug Administration.  The drug, Perjeta, is a Genentech drug … Continue reading →